CROI 2017 Abstract e-Book

Abstract eBook

Keyword Index

Single nucleotide polymorphism 530 Single-tablet regimen 424, 427 SIV 172, 178, 217, 260LB, 62LB, 69 SIV escape 179 SIVgor 218 Smoking 130, 131, 628, 654 Smoking cessation 131, 654 Snapshot analysis 444 SNP 643 Social deprivation 736 Social determinants of health 921, 923, 926 Social network 36, 836, 849 Social support 36 Sofosbuvir 568LB, 573 Soluble biomarkers 205, 381

Tensor-based morphometry 397 Test and Treat 863, 910, 915, 917, 1007, 1011 Testing 33, 728, 762, 980, 1046 Tetanus toxoid C fragment oligomers 785 Text message 964 Tfh 221, 250, 258, 262, 62LB, 63 Th1 cells 223 Th17 cells 204, 223 Thailand 584LB, 855 Therapeutic vaccine 333 Therapy 227 Third line 488, 1020 Thrombosis 609 TIGIT 255, 337 Time to ART initiation 1007, 817LB Tissue 320, 407 Tissue-type plasminogen activator 616 TLR 118, 313, 314 TMAO 625 TMC278 LA 421LB Total HIV-1 DNA 28, 234, 285 Total nucleic acid 508 Toxicity 378 Toxoplasmic encephalitis 751 Trail 273 Trajectory 351 Transcription 168 Transcriptional networks 739 Transcriptionally active proviruses 294, 312 Transgender 846, 897, 923, 926 Transmission 1048, 32, 67, 845LB · Biology 170, 181LB · Cluster 184, 477, 1026 · Network 77, 184, 185, 186, 187, 188, 189 · Pairs 181LB · Risk 1045 Transmitted drug resistance 477, 480, 491, 504LB Transmitted founder HIV-1 181LB Transplantation 317, 689 Treatment 136, 560, 724LB, 835, 852 · As prevention 32, 476, 1003, 1011, 1042, 1048 · Experienced 449LB · Gap 619 · Interruption 124, 363, 796 · Naive 500LB, 45LB, 491 · Outcomes 472, 714, 718, 722, 1021 · Scale up 1040, 1043 Trends 600, 831, 852, 865, 906 Trimethoprim 811 Tropism 73, 177 Tryptophan catabolism 212 Transcriptome 61 Transduction 21

Urine tenofovir testing 975 Urothelial vacuolation 434 US National HIV/AIDS Strategy 1043 USP18 161 V3-loop 177 Vaccination 582, 804 Vaccine 1057LB, 119LB, 245, 246 Vaccine response 275, 785, 803 VACS index 354, 626, 668

Vaginal ring 952 Valacyclovir 447 Vascular 402, 616, 823, 824 VCAM-1 824 Venous thrombosis 620 Vertically HIV-infected 821 Vif 172, 173 Violence 923, 925, 926 Viral · Assembly 21, 154 · Decay 325, 446 · Fitness 178, 179, 268 · Kinetics 570 · Load 170, 237LB, 32, 624, 765, 767, 768, 868LB, 881, 889, 890, 917, 988, 989, 992 · Migration 182 · Particles 154 · Persistence 932 · Rebound 125, 306, 336, 363 · Replication 178, 217 · Reservoir 69, 312, 321, 363 · Sequences 217 · Suppression 24, 27, 31, 35, 479, 638, 644, 769, 771, 838, 874, 907, 912, 922, 933, 1013, 1014, 1045 · Viral trajectory 646 Viremia 624, 932 Viremia copy-years 624, 931 Viremic nonprogressor 236, 245 Virologic · Control 119LB · Failure 1002, 500LB, 909, 932 · Response 768, 808, 952 · Suppression 113, 258, 947, 1002, 1012, 841LB · Treatment failure 462 Vision loss 749 Visit intervals 1000 Vitamin D 617, 645, 682, 685LB, 820, 822 Vpx 174 Vpx lentiviral vectors 333 VRC01 330LB Vulnerable populations 557, 851, 925, 1016 Weight gain 695, 699 Weight loss 694 West Africa 642 White matter abnormalities 68 White MSM 872 WHO recommended 1st-line regimens 485, 504LB Women 85, 132, 210, 281, 350, 361, 367, 443, 599, 627, 629, 690, 836, 851, 852, 859, 873, 874, 913, 921, 924, 925, 936, 939, 940, 942, 970 X-ray Crystallography 171LB XDR-TB 80LB

Soluble urokinase plasminogen activator receptor 235 South Africa 24, 111, 489, 657, 725, 771, 823, 917, 958, 983, 990, 991, 1007, 1019, 1021, 1050 Spatial mapping 77 Spectral domain optical coherence tomography 396 Spillover effects 960 Spirometry 654 Splicing 163 ST2 630

Statins 468, 617, 619, 640, 674 Steady state drug levels 431 Steatosis 525, 697, 701, 702 Stem cell transplantation 319, 320, 332 Stigma 918, 919, 920, 921, 924, 926 Stillbirth 25

Strategy Trial 720 Stroke 346, 347, 348 Structure 246 Sub-Saharan Africa 78, 850, 857, 936, 947, 1003, 1027 Subsequent pregnancy 772 Substance use 133, 547, 838, 925, 977, 557 Subtypes 193, 202, 386, 879 Sulfamethoxazole 811 Superinfection 200, 201, 242 Suppression 32, 988 Suppressive ART 350 Surveillance 30, 35, 478, 479, 504LB, 577, 885, 89, 899, 904,

Keyword Index

31, 846, 851, 889, 906, 910 Survey research 114LB Survival 603 Sustained virologic response SVR 552, 569, 570 Swaziland 475, 708 Switching regimen 44LB, 807 Symptoms 655 Syndromic diagnosis 950 Syphilis 339, 749, 750, 862, 864, 866, 91LB T cell 37, 221, 263, 799 · Activation 207, 208, 275, 313, 948 · Exhaustion 255, 385 · Immunity 118, 261, 948 · Receptor 269 · Subsets 257, 264, 293 · Trafficking 209

Tuberculosis 29LB, 657, 709, 712, 713, 716LB, 719, 721, 723LB, 724LB, 725, 726, 730, 735, 76LB, 78, 79, 80LB, 287, 706, 711, 714, 718, 720, 727, 728, 729, 733, 734, 739, 77, 81LB, 705, 707, 730 Type 1 interferon 254 UB-421 450LB Uganda 33, 193, 359, 675, 832, 880, 915, 996, 1001, 1015, 1048 Ukraine 884 Ultradeep sequencing 495 UNAIDS 90-90-90 115, 1011, 1042 Uncoating 15 Undiagnosed HCV 903

T follicular 63, 1057LB, 264, 265LB, 62LB Talaromyces marneffei 83, 747, 748 Talaromycosis 83 Tanzania 950 Targeted screening 956 Tat 303 TB 238, 722, 729, 730, 736 TB LAMP 712 Telomere length 388, 590, 652 Temporal trends 1027

YKL-40 383 Young 912 · Adults 403, 813, 833, 839, 864, 975 · Black MSM 90, 188, 849, 975 · Young women 857, 949 Zambia 581, 1000, 1004 Zika virus 1054, 1055LB, 1056LB, 1057LB Zimbabwe 115, 345, 743, 984, 1030 Zoledronic acid 684

Undiagnosed HIV 900, 903, 904, 914 Undocumented immigrant 1016 Unfolded Protein Response 74 United Kingdom 831 United States 737, 871, 1033 Universal test and treat 475, 1018, 1047 Urine tenofovir assay 975

Tenofovir 138, 277, 405, 408, 411, 414, 418, 420, 485, 652, 686, 86LB, 949, 954, 41, 406, 424, 443, 453, 683, 404, 406, 453, 584LB, 650, 683, 685LB, 783, 953, 954, 981

CROI 2017 491